Quantcast

Latest Healthcare in India Stories

2010-10-04 07:00:00

REDWOOD CITY, Calif., Oct. 4 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. announced today that James H. Welch has joined the company as Chief Financial Officer. "We are very fortunate to continue to attract seasoned leaders in the pharmaceutical industry," stated Richard King, AcelRx President and CEO. "Jim brings over two decades' experience in financial and operational management at life science and high technology firms. His addition to the AcelRx team positions us well for future...

2010-10-04 06:30:00

CALGARY, Oct. 4 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and Chief Executive Officer of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 9th Annual BIO Investor Forum on Wednesday, October 6th, 2010 at 8:00 a.m. PDT. The conference takes place on October 5th and 6th at the Palace Hotel in San Francisco, CA. A live audio link to the webcast presentation is available at:...

2010-09-27 06:30:00

CALGARY, Sept. 27 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and Chief Executive Officer of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 5th annual JMP Securities Healthcare Conference on Tuesday, September 28th, 2010 at 10:00 a.m. EDT. The conference takes place from September 27th to 28th at the New York Palace Hotel in New York, NY. A live audio link to the webcast presentation is available at:...

2010-09-22 18:00:00

SINGAPORE, Sept. 23 /PRNewswire/ -- S*BIO Pte Ltd today announced a US$5 million investment by Mitsui Ventures that will support the continued development of S*BIO's clinical programs. "Mitsui Ventures' financing commitment reflects the international investment community's strong interest in our track record in advancing multiple assets through clinical development and the quality of our various preclinical and clinical programs," said Dr. Jan-Anders Karlsson, CEO of S*BIO. "The...

2010-09-15 10:00:00

SAN DIEGO, Sept. 15 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today that it has been named to the annual FierceBiotech "Fierce 15" list, designating it as one of the top and most promising biotech companies in the industry. Every year, FierceBiotech evaluates hundreds of private companies, which is based...

2010-09-09 06:30:00

CALGARY, Sept. 9 /PRNewswire-FirstCall/ - Mr. Doug Ball, Chief Financial Officer of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 14th, 2010 at 10:25 a.m. EDT. The conference takes place from September 12th to 15th at the New York Palace Hotel in New York, NY. A live audio link to the webcast presentation is available at:...

2010-09-07 18:00:00

SAN DIEGO, Sept. 7 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences: Morgan Stanley Global Healthcare -- Conference Date: Tuesday, September 14, 2010 Time:...

2010-09-01 07:00:00

SAN DIEGO, Sept. 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the Rodman & Renshaw Annual Global Investment Conference on Tuesday September 14, 2010 at 11:40 a.m. Eastern time, in the Hubbard Salon at the New York Palace Hotel in New York. Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals website at...

2010-09-01 03:59:00

OXFORD, England and LANGHORNE, Pennsylvania, September 1, 2010 /PRNewswire/ -- EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced the appointment of Stephen A. Stamp to the company's Board as an independent Non-Executive Director. Mr Stamp has extensive experience of the specialty pharmaceutical sector having previously held Board-level roles at Xanodyne Pharmaceuticals Inc. and Shire Pharmaceuticals Plc,...

2010-08-06 12:59:00

MADRID, August 6, 2010 /PRNewswire/ -- The Spanish Bioindustry Association (ASEBIO), in collaboration with the Navarre Society of Development (SODENA), and the government of Navarre, will host BioSpain 2010 (http://www.biospain.org), the biennial international gathering of experts in the biotechnology sector, in Pamplona from September 29th to October 1st. BioSpain 2010 is honoured to welcome three lecturers of international prestige: Mr. Carlos Cordon-Cardo, Vice-Chair of Pathology &...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related